To save $$, use genetic testing to discern which diagnostic tests should be done and on whom and which therapies should be used and on whom.
Insurance and Medicare/Medicaid does not pay for genetic testing to conclude the basic genetic predisposition of beneficiaries, its future medical service recipients. If testing were routine routine preventative diagnostic tests could be focused on those with predisposition and done less often on those without a family history and predisposition, saving many more dollars than the one time cost of the tests. Same is true of pharmaceutical therapies, such as statins. Why prescribe expensive statins for an individual with no family history of heart disease, a calcium score of zero, and a negative Kif6 genetic test. It is a waste of money, even if that individual has an unacceptably high cholesterol level. Disclaimer...I have no interest in or stock position in any genetic testing company.